Top Markets
#1 PulseChain PulseChain +45.13%
#2 Glidr Glidr +11.05%
#3 Fake World Assets Fake World Assets +9.47%
#4 Meteora Meteora +7.99%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.90%
#6 eCash eCash +6.72%
#7 Qkacoin Qkacoin +6.49%
#8 OPENLOOT OPENLOOT +5.89%
#9 Velvet Velvet +5.57%
#10 Tornado Cash Tornado Cash +5.56%
Coin of the day
PulseChain PulseChain
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Rang in Aktien #28267
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Aktienkurs
$0.3958979
Marktkapitalisierung
$27.40M
Veränderung (1 Tag)
-0.40%
Veränderung (1 Jahr)
-48.96%
Land
TW
Handel LAUNXP Biomedical Co., Ltd (6876)

Kategorie

Healthcare
Kursverlauf für LAUNXP Biomedical Co., Ltd (6876)
Höchster Schlusskurs: $0.37 am 2026-08-01

Niedrigster Schlusskurs: $0.71 am 2024-01-01
Kursverlauf der Aktie von LAUNXP Biomedical Co., Ltd von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -9.54%
2025 17.29%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.86 -14.20%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 5.84%
CH